Crossmark

FGFR leads to sustained activation of STAT3 to mediate resistance to EGFR-TKIs treatment

Published Online: 2021-04-07

Published Print: 2021-10

Authors

Song, Xiaoping http://orcid.org/0000-0003-4567-5944
Tang, Wei

Peng, Hui

Qi, Xin

Li, Jing
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No. 81673450)

NSFC Shandong Joint Fund (U1606403, U1906212)

Scientific and Technological Innovation Project was financially supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ02)

National Science and Technology Major Project for Significant New Drugs Development (2018ZX09735-004)

Shandong Provincial Natural Science Foundation (ZR2019ZD18)

Scientific Research Plan Projects of Shaanxi Education Department (No. 19JK0850)
License Information

Text and Data Mining valid from 2021-04-07

Version of Record valid from 2021-04-07
More Information

Article History

Received: 5 November 2020

Accepted: 1 January 2021

First Online: 7 April 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The participant has consented to the submission of this report to the journal.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Informed consent was obtained from all individual participants included in the study.

: Not applicable.

Document is current